Literature DB >> 26552405

Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation.

Jun Hu1, Jun Liu2.   

Abstract

Licochalcone A (Lico A), a flavonoid found in licorice root (Glycyrrhiza glabra), has been reported to have anti-inflammatory activity. However, the protective effects of Lico A on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) remains unclear. In this study, using a mouse model of LPS-induced AKI, we investigated the protective effects and mechanism of Lico A on LPS-induced AKI in mice. LPS-induced kidney injury was assessed by detecting kidney histological study, blood urea nitrogen (BUN), and creatinine levels. The production of inflammatory cytokines TNF-α, IL-6, and IL-1β in serum and kidney tissues was detected by ELISA. The activation of NF-κB was measured by western blot analysis. Our results showed that Lico A dose-dependently attenuated LPS-induced kidney histopathologic changes, serum BUN, and creatinine levels. Lico A also suppressed LPS-induced TNF-α, IL-6, and IL-1β production both in serum and kidney tissues. Furthermore, our results showed that Lico A significantly inhibited LPS-induced NF-κB activation. In conclusion, our results suggest that Lico A has protective effects against LPS-induced AKI and Lico A exhibits its anti-inflammatory effects through inhibiting LPS-induced NF-κB activation.

Entities:  

Keywords:  LPS; NF-κB; acute kidney injury; licochalcone A

Mesh:

Substances:

Year:  2016        PMID: 26552405     DOI: 10.1007/s10753-015-0281-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  27 in total

1.  Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo.

Authors:  Xiao Chu; Xinxin Ci; Miaomiao Wei; Xiaofeng Yang; Qingjun Cao; Mingfeng Guan; Hongyu Li; Yanhong Deng; Haihua Feng; Xuming Deng
Journal:  J Agric Food Chem       Date:  2012-04-06       Impact factor: 5.279

Review 2.  Inflammation in acute kidney injury.

Authors:  Gilbert R Kinsey; Li Li; Mark D Okusa
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

Review 3.  Sepsis and acute kidney injury.

Authors:  Abolfazl Zarjou; Anupam Agarwal
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

4.  Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-κB signaling pathway.

Authors:  Daliang Xu; Maosheng Chen; Xianzhi Ren; Xianguo Ren; Yonggui Wu
Journal:  Fitoterapia       Date:  2014-06-09       Impact factor: 2.882

5.  CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury.

Authors:  Dong Hun Lee; Mi Hee Park; Chul Ju Hwang; Jae Yeon Hwang; Hae Suk Yoon; Do Young Yoon; Jin Tae Hong
Journal:  Arch Toxicol       Date:  2015-06-09       Impact factor: 5.153

6.  Serum creatine kinase levels and renal function measures in exertional muscle damage.

Authors:  Priscilla M Clarkson; Amy K Kearns; Pierre Rouzier; Richard Rubin; Paul D Thompson
Journal:  Med Sci Sports Exerc       Date:  2006-04       Impact factor: 5.411

7.  Plasma cytokine levels predict mortality in patients with acute renal failure.

Authors:  Edith M Simmons; Jonathan Himmelfarb; M Tugrul Sezer; Glenn M Chertow; Ravindra L Mehta; Emil P Paganini; Sharon Soroko; Stephanie Freedman; Karen Becker; Daniel Spratt; Yu Shyr; T Alp Ikizler
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

Review 8.  Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury.

Authors:  Andrew A House; Claudio Ronco
Journal:  Blood Purif       Date:  2008-01-10       Impact factor: 2.614

Review 9.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis.

Authors:  Chang Xu; Anthony Chang; Bradley K Hack; Michael T Eadon; Seth L Alper; Patrick N Cunningham
Journal:  Kidney Int       Date:  2013-07-31       Impact factor: 10.612

View more
  12 in total

1.  IL-35 Pretreatment Alleviates Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Inhibiting NF-κB Activation.

Authors:  Linkun Hu; Cheng Chen; Jun Zhang; Kerong Wu; Xuefeng Zhang; Haiyan Liu; Jianquan Hou
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

2.  Telluric Acid Ameliorates Endotoxemic Kidney Injury in Mice: Involvement of TLR4, Nrf2, and PI3K/Akt Signaling Pathways.

Authors:  Ahmed F Mohamed; Marwa M Safar; Hala F Zaki; Helmy M Sayed
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Chlorogenic Acid Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting TLR4/NF-κB Signal Pathway.

Authors:  Han-Yang Ye; Jian Jin; Ling-Wei Jin; Yan Chen; Zhi-Hong Zhou; Zhan-Yuan Li
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

4.  The protective effect and mechanism of lentinan on acute kidney injury in septic rats.

Authors:  Xiaoping Li; Wanfen Zhang; Ping Li; Guoyuan Lu
Journal:  Ann Transl Med       Date:  2020-07

5.  Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo.

Authors:  Hongrui Cui; Guangwei Ren; Xiuhong Hu; Baozhen Xu; Yuping Li; Zheli Niu; Liqin Mu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 6.  Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

Authors:  Pritam Thapa; Sunil P Upadhyay; William Z Suo; Vikas Singh; Prajwal Gurung; Eung Seok Lee; Ram Sharma; Mukut Sharma
Journal:  Bioorg Chem       Date:  2021-01-29       Impact factor: 5.307

7.  Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro.

Authors:  Bo Liu; Fengxia Ding; Dong Hu; Yu Zhou; Chunlan Long; Lianju Shen; Yuanyuan Zhang; Deying Zhang; Guanghui Wei
Journal:  Stem Cell Res Ther       Date:  2018-01-12       Impact factor: 6.832

8.  Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.

Authors:  Bingxu Huang; Juxiong Liu; Chen Ju; Dongxue Yang; Guangxin Chen; Shiyao Xu; Yalong Zeng; Xuan Yan; Wei Wang; Dianfeng Liu; Shoupeng Fu
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

9.  Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.

Authors:  Li-Ming Lien; Kuan-Hung Lin; Li-Ting Huang; Mei-Fang Tseng; Hou-Chang Chiu; Ray-Jade Chen; Wan-Jung Lu
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

Review 10.  Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.

Authors:  Yufan Wu; Zhuxian Wang; Qunqun Du; Zhaoming Zhu; Tingting Chen; Yaqi Xue; Yuan Wang; Quanfu Zeng; Chunyan Shen; Cuiping Jiang; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.